• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Artificial leaf produces drugs using solar energy

December 21, 2016 By Sarah Faulkner

Artificial leaf produces drugs using solar energyResearchers from the Eindhoven University of Technology have reportedly developed a leaf-inspired mini-factory to produce drugs using solar energy. The team’s work could allow medicine to be made in resource-deprived areas, as long as there is sunlight.

“Theoretically, you could use this device to make drug compounds with solar energy anywhere you want,” lead researcher Timothy Noël said, according to Reuters. 

Using luminescent solar concentrators, the artificial leaf mimics nature and efficiently harvests solar radiation. Liquid is pumped through tiny channels, exposing molecules to sunlight with enough intensity to kick-start a chemical reaction.

The team said in a statement that removing the need for a power grid could one day enable researchers to make malaria drugs in the jungle or medicines on Mars.

This is not the 1st biomimetic device or product that makes use of a process found in nature. Pfizer (NYSE:PFE) and Protaliz Biotherapeutics made a drug for a rare genetic condition known as Gaucher disease using genetically modified carrot cells. Other research teams are growing crops that have been genetically bred to produce medicines and vaccines in their leaves, Reuters reported.

The artificial leaf will still work in places with cloudy skies and even though each small unit relies on micro-channels, Noël believes researchers could link the devices together and increase production.

“Even an experiment on a cloudy day demonstrated that the chemical production was 40 percent higher than in a similar experiment without LSC material,” Noël said in the University’s press release. “We still see plenty of possibilities for improvement. We now have a powerful tool at our disposal that enables the sustainable, sunlight-based production of valuable chemical products like drugs or crop protection agents.”

Noël told the news outlet that the process could become available to chemical engineers within 5 to 10 years.

Filed Under: Drug-Device Combinations, Featured, Materials Testing, Pharmaceuticals, Research & Development, Technology Tagged With: Eindhoven University of Technology, Pfizer Inc.

IN CASE YOU MISSED IT

  • BD stock up on Street-beating preliminary quarterly revenue numbers
  • Locate Bio lands FDA breakthrough nod for bone infection device
  • PerkinElmer to acquire Oxford Immunotec
  • Evonik buys polymers business from Durect Corp.
  • New Croatian notified body designated to European MDR

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS